TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Turn Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.74+0.17 (+1.61%)
Close on Oct 19, 2026
- Market cap
- $319.92M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.9%
1M of 30M shares
Institutional holders
29
11 new, 2 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $117.75K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bradley Burnam | 15,716,260 | 52.76% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TTRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| SteelPeak Wealth, LLC | 249,456 | 0.84% | $1.82M | New | 0.05% |
| Ieq Capital, LLC | 227,396 | 0.76% | $1.66M | New | 0.01% |
| DDFG, Inc | 107,829 | 0.36% | $787.15K | +37,295 | 0.16% |
| Vanguard Capital Management LLC | 74,301 | 0.25% | $542.40K | +24,851 | 0.00% |
| Wellington Shields & Co., LLC | 65,732 | 0.22% | $479.84K | – | 0.11% |
| Millennium Management LLC | 60,551 | 0.20% | $442.02K | −9,206 | 0.00% |
| BlackRock, Inc. | 38,591 | 0.13% | $281.72K | New | 0.00% |
| Aaron Wealth Advisors LLC | 32,564 | 0.11% | $237.72K | New | 0.01% |
| Tamar Securities, LLC | 30,000 | 0.10% | $219.00K | – | 0.02% |
| Royal Bank of Canada | 28,250 | 0.09% | $206.00K | New | 0.00% |
| Bridgewater Advisors Inc. | 27,326 | 0.09% | $241.56K | New | 0.01% |
| Citadel Advisors LLC | 25,874 | 0.09% | $188.88K | New | 0.00% |
| Brown Brothers Harriman & Co | 23,688 | 0.08% | $172.92K | – | 0.00% |
| HighTower Advisors, LLC | 19,684 | 0.07% | $143.69K | – | 0.00% |
| RVW Wealth, LLC | 18,000 | 0.06% | $131.40K | – | 0.01% |
| Geode Capital Management, LLC | 17,142 | 0.06% | $125.14K | – | 0.00% |
| Jefferies Financial Group Inc. | 16,300 | 0.05% | $118.99K | New | 0.00% |
| Miracle Mile Advisors, LLC | 16,000 | 0.05% | $116.80K | – | 0.00% |
| McCarthy Asset Management, Inc. | 15,018 | 0.05% | $109.63K | New | 0.05% |
| Bank Of America Corp /De/ | 14,124 | 0.05% | $103.11K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 1M | 3.9% | 11 / 4 | 2 / 2 | 1M | 0M |
| Q1 2026 | 20 | 0M | 1.6% | 3 / 3 | 2 / 4 | 0M | 0M |
| Q4 2025 | 22 | 0M | 1.6% | 22 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TTRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 62,749 | 0.21% | $458.07K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 36,232 | 0.12% | $264.49K | 0.02% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 17,142 | 0.06% | $89.14K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 9,897 | 0.03% | $72.25K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 2,359 | 0.01% | $17.22K | 0.01% | Jun 30, 2026 |
| Victory Extended Market Index Fund | 1,244 | 0.00% | $10.40K | 0.00% | Jul 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 129 | 0.00% | $942 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Bradley Evan Burnam | Chief Executive Officer, Director, 10% owner | 15,416,260 | 51.75% | Jun 1, 2026 |
| Neilesh Shailesh Ghodadra | Chief Medical Officer, Director | 10,000 | 0.03% | Oct 10, 2025 |
| Zuraiz Chaudhary | See Remarks | 12,500 | 0.04% | Apr 3, 2026 |
| Kent Edward Kester | Director | 10,000 | 0.03% | Jun 8, 2026 |
| Andrew Gengos | Director | 10,000 | 0.03% | Jun 8, 2026 |
| Martin William Dewhurst | Director | 21,882 | 0.07% | Jun 8, 2026 |
| Arthur F. Golden | Director | 360,602 | 1.21% | Jun 8, 2026 |
| BEB Holdings, LLC | 10% owner | 15,716,260 | 52.76% | Jun 1, 2026 |
| Abraham Chesed | – | 1,447,268 | 4.86% | Oct 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | −300,000 | – | – | 15,116,260 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | +300,000 | – | – | 300,000 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | −300,000 | – | – | 15,416,260 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | +300,000 | – | – | 300,000 |
| Arthur F. Golden Director | Apr 2, 2026 | Gift | +300,000 | – | – | 360,602 |
| BEB Holdings, LLC 10% owner | Apr 2, 2026 | Gift | −300,000 | – | – | 15,716,260 |
| Martin William Dewhurst Director | Jan 7, 2026 | Award | +21,882 | – | – | 21,882 |
| Zuraiz Chaudhary See Remarks | Dec 12, 2025 | Buy | +2,500 | $3.50 | $8.75K | 12,500 |
| Arthur F. Golden Director | Nov 24, 2025 | Buy | +9,868 | $3.44 | $33.95K | 60,602 |
| Arthur F. Golden Director | Nov 21, 2025 | Buy | +20,532 | $2.87 | $58.93K | 50,734 |
| Zuraiz Chaudhary See Remarks | Nov 21, 2025 | Buy | +1,000 | $3.29 | $3.29K | 10,000 |
| Zuraiz Chaudhary See Remarks | Nov 20, 2025 | Buy | +1,450 | $2.61 | $3.78K | 9,000 |
| Zuraiz Chaudhary See Remarks | Nov 17, 2025 | Buy | +2,500 | $3.62 | $9.05K | 7,550 |
| Abraham Chesed – | Oct 23, 2025 | Buy | +14,286 | $4.60 | $65.72K | 1,447,268 |
| Arthur F. Golden Director | Oct 23, 2025 | Buy | +20,202 | $4.95 | $100.00K | 30,202 |
| Zuraiz Chaudhary See Remarks | Oct 23, 2025 | Buy | +5,050 | $4.95 | $25.00K | 5,050 |
| Neilesh Shailesh Ghodadra Chief Medical Officer, Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Andrew Gengos Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Arthur F. Golden Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Kent Edward Kester Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.